Apotheek Lierseweg

Active

Private limited companyfounded 2011active for 15 yearsLierseweg(HRT) 177, 2200 Herentals, BelgiumKBO/BCE: BE 0837.740.696

Summary

Apotheek Lierseweg has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €537,085 and a net result of €163,929. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 45% of 12,713 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

Apotheek LiersewegActiveChecked score 93/100

Risk analysis Report Compare

Activity

Retail sale of pharmaceutical products

NACE 47730

1 site

Size

≈ €1.4mturnover 2025, estimated

Staff: 2.5 FTE
Equity: €537,085
Profit: €163,929

Turnover estimated from the gross margin

Financial health

93 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.1%

Structure

Parent: K & T · 100%

K & TDirector · permanent representative DE GROOF Karolien Marie Jan

2025 accounts 38 days early1 of 4 deeds summarised

Why 93lowers riskFigures for financial year 2025 (filed 23-06-2026)Founded in 2011Liquidity: current ratio 2.17, cash €307,534Size: 2.5 FTE, total assets €1.7mShow the evidence

Checked score

Score 2025

93 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 64% of its sector peers (NACE 47, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2025

Strong

Solvency 57+7

equity 32.0% of total assets

Liquidity 66+5

short-term debt 21.4% · cash 18.3%

Profitability 81+2

return on assets 9.8%

Bankruptcy probability, 12 months

0.1% Very low

0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,263 companies, NACE 47, micro)

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025highest value 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.1%▼ -0.1 percentage points vs 09-2026lowest value

Credit of up to €45,000 on 30-day terms is acceptable

Liquidity ample (current ratio 2.17, above the usual 1.5; short-term debt: 21.4% and cash: 18.3% of total assets), but 68% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 48% on solvency, 72% on liquidity and 73% on profitability.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Figures for financial year 2025 (filed 23-06-2026)

NBB · annual accounts

Founded in 2011

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Liquidity: current ratio 2.17, cash €307,534

NBB · annual accounts

Size: 2.5 FTE, total assets €1.7m

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

38 days early

2025

32 days early

2024

20 days early

2023

35 days early

2022

3 days late

2021

2 days late

2020

30 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 21 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

23-06-2026 Annual accounts filedfinancial year 2025 · abbreviated…
31-12-2025 Equity above €500,000equity €537,085 ▲43.9%
17-11-2025 Resignation: DE GROOF Karolien Marie Jan…Appointment: K & T (director)…

Key points

Caution: Board changedlatest change 17-11-2025 · 1 in office 1 joined · 1 left View
Positive: Among the best 15% on net resultsector median €27,714 · 12,703 companies €163,929 View
Controlled by K & T 100% View
Positive: Filed on time since financial year 2023accounts within the deadline every year 4 years View

By topic

Financials

Financial year: 2025
Total assets: €1.7m
Profit: €163,929
Solvency: 32.0%

Total assets▲ 10.2%

Net result

20192025

Go to Financials

Board & ownership

Board: 1 member
Parent: K & T · 100%

K & TDirector

Go to Board & ownership

Timeline

Events: 20
Since: 2014

29-09-2025Annual accounts filed
11-10-2024Annual accounts filed
31-03-2024Highest result from 2019 to 2025

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Retail sale of pharmaceutical productsNACE 47730
Founded: 04-07-2011
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 2

Annual meeting: Last Monday of May at 19:00

Go to Articles of association

Key facts about Apotheek Lierseweg

What is the company number of Apotheek Lierseweg?: 0837.740.696. In Belgium the VAT number is the company number with BE in front: BE 0837.740.696.
Where is Apotheek Lierseweg based?: The registered office is at Lierseweg(HRT) 177, 2200 Herentals.Company details
What does Apotheek Lierseweg do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Lierseweg?: Private limited company (BV).
When was Apotheek Lierseweg founded?: On 04-07-2011.
Is Apotheek Lierseweg still active?: Yes, Apotheek Lierseweg is an active enterprise in the KBO register.
How many employees does Apotheek Lierseweg have?: On average 2.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Lierseweg?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Apotheek Lierseweg profitable?: In financial year 2025, Apotheek Lierseweg made a profit of €163,929.
Where can I find the annual accounts of Apotheek Lierseweg?: Apotheek Lierseweg filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.